WallStreetZenWallStreetZen

NASDAQ: PARK
Park Dental Partners Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their PARK stock forecasts and price targets.

Forecast return on equity

Is PARK forecast to generate an efficient return?

Company
28.52%
Industry
-56.25%
Market
133.58%
PARK's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PARK forecast to generate an efficient return on assets?

Company
4.03%
Industry
9.14%
PARK is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PARK earnings per share forecast

What is PARK's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$1.55
Avg 2 year Forecast
$1.61

PARK revenue forecast

What is PARK's revenue in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$262.7M
Avg 2 year Forecast
$278.9M

PARK vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
PARK$18.96N/AN/A
PIII$11.58$14.00+20.90%Buy
BTMD$2.34$2.83+21.07%Strong Buy
NAKA$4.31$30.00+596.06%Strong Buy
SRXH$0.12N/AN/A
View Top Medical Care Facility Stocks

Park Dental Partners Stock Forecast FAQ

What is PARK's earnings growth forecast for 2026-2027?

(NASDAQ: PARK) Park Dental Partners's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 12.46%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,348.4%.

Park Dental Partners's earnings in 2026 is N/A.On average, 4 Wall Street analysts forecast PARK's earnings for 2026 to be $7,000,140, with the lowest PARK earnings forecast at $6,415,892, and the highest PARK earnings forecast at $7,537,883.

In 2027, PARK is forecast to generate $7,253,434 in earnings, with the lowest earnings forecast at $6,150,407 and the highest earnings forecast at $8,343,820.

If you're new to stock investing, here's how to buy Park Dental Partners stock.

What is PARK's revenue growth forecast for 2026-2027?

(NASDAQ: PARK) Park Dental Partners's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 5.28%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.75%.

Park Dental Partners's revenue in 2026 is N/A.On average, 4 Wall Street analysts forecast PARK's revenue for 2026 to be $1,186,285,288, with the lowest PARK revenue forecast at $1,135,310,328, and the highest PARK revenue forecast at $1,225,972,613.

In 2027, PARK is forecast to generate $1,259,384,012 in revenue, with the lowest revenue forecast at $1,186,375,589 and the highest revenue forecast at $1,321,736,908.

What is PARK's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: PARK) forecast ROA is 4.03%, which is lower than the forecast US Medical Care Facilities industry average of 9.14%.

What is PARK's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: PARK) Park Dental Partners's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that PARK's EPS will be $1.55 for 2026, with the lowest EPS forecast at $1.42, and the highest EPS forecast at $1.67. In 2027, PARK's EPS is forecast to hit $1.61 (min: $1.36, max: $1.85).

What is PARK's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: PARK) forecast ROE is 28.52%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.